Position in ABBV
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$6,316,415
+$945,500 QoQ
Shares Held
25,101
+1.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
3.16%
of 13F equity value
Holder Rank
#1,173
of 4,152 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Founders Capital Management holds $23,776,064 across 8 Drug Manufacturers - General names. ABBV ranks #2 (26.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
46,663 | $11,851,002 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
25,101 | $6,316,415 | |
| 3 | MRK |
Merck & Co., Inc.
|
38,583 | $4,957,915 | |
| 4 | PFE |
Pfizer Inc
|
13,473 | $324,429 | |
| 5 | AMGN |
Amgen Inc
|
409 | $148,107 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
1,500 | $86,430 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
512 | $64,686 | |
| 8 | OGN |
Organon & Co.
|
2,000 | $27,080 |
All Filings in ABBV
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,316,415 | 25,101 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $5,370,915 | 24,695 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $5,659,925 | 24,771 | Shares | Sole | 2026-01-15 | |
| 2025-09-30 | $5,764,419 | 24,896 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $4,672,612 | 25,173 | Shares | Sole | 2025-07-18 | |
| 2025-03-31 | $5,305,255 | 25,321 | Shares | Sole | 2025-04-08 | |
| 2024-12-31 | $5,602,703 | 31,529 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | $6,441,600 | 32,619 | Shares | Sole | 2024-10-07 | |
| 2024-06-30 | $5,635,804 | 32,858 | Shares | Sole | 2024-07-10 | |
| 2024-03-31 | $6,096,708 | 33,480 | Shares | Sole | 2024-04-10 | |
| 2023-12-31 | $5,234,421 | 33,777 | Shares | Sole | 2024-01-08 | |
| 2023-09-30 | $5,089,057 | 34,141 | Shares | Sole | 2023-10-10 | |
| 2023-06-30 | $4,799,756 | 35,625 | Shares | Sole | 2023-07-07 | |
| 2023-03-31 | $5,670,065 | 35,578 | Shares | Sole | 2023-04-12 | |
| 2022-12-31 | $5,809,879 | 35,950 | Shares | Sole | 2023-01-09 | |
| 2022-09-30 | $4,823,641 | 35,941 | Shares | Sole | 2022-10-06 | |
| 2022-06-30 | $5,546,995 | 36,217 | Shares | Sole | 2022-07-20 | |
| 2022-03-31 | $6,246,422 | 38,532 | Shares | Sole | 2022-04-07 | |
| 2021-12-31 | $5,217,232 | 38,532 | Shares | Sole | 2022-01-21 | |
| 2021-09-30 | $4,186,542 | 38,811 | Shares | Sole | 2021-10-12 | |
| 2021-06-30 | $4,711,505 | 41,828 | Shares | Sole | 2021-07-15 | |
| 2021-03-31 | $4,556,927 | 42,108 | Shares | Sole | 2021-06-09 | |
| 2020-12-31 | $4,735,815 | 44,198 | Shares | Sole | 2021-01-12 | |
| 2020-03-31 | $3,818,947 | 50,124 | Shares | Sole | 2020-04-22 | |
| No filing history on record for this holder in this stock. | ||||||